← Eichor
Study identifier: NCT07290517 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Assessing Pain and Effectiveness of Carevix Device for IUD Insertions

Condition: IUD · Abnormal Uterine Bleeding · Pain, Cervical  ·  Sponsor: Indiana University

PhaseNA
Planned participants100
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to evaluate patient-reported pain, bleeding, and device efficiency along with provider satisfaction and ease of use between IUD insertions using a suction cervical stabilizer (new device, FDA approved, atraumatic) and single-tooth tenaculum (standard, traumatic). Our aims are to: * assess and compare patient-reported pain during IUD insertion between the Carevix device and tenaculum. * assess predictors of pain scores including between nulliparous and multiparous patients * assess provider-reported ease of use and satisfaction Participants (including providers) will: * be randomized to receive one device to complete the IUD procedure * complete a survey following the procedure

This description comes directly from the study's public registry record.

Talk to the study team

Alissa M Conklin, MD  ·  317-944-8231  ·  alconkli@iu.edu

Kylie L Williams, MA  ·  kylowill@iu.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Indiana University HospitalIndianapolis, Indiana, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07290517